Microbiome

Filter
  • Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
  • Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease
  • Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease
  • Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn’s disease
  • High prevalence of adherent-invasive *Escherichia coli* associated with ileal mucosa in Crohn’s disease
  • Anti-*Saccharomyces cerevisiae* mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role
  • Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn’s disease
  • Antibodies to Saccharomyces cerevisiae in patients with Crohn’s disease and their possible pathogenic importance.
  • Mycobacterium paratuberculosis DNA in Crohn’s disease tissue
  • Serum Antibodies Reactive with *Saccharomyces cerevisiae* in Inflammatory Bowel Disease: Is IgA Antibody a Marker for Crohn’s Disease?